Amgen Announces $5 Billion Stock Repurchase Plan

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Dec. 7, 2005--Amgen (NASDAQ:AMGN), the world’s largest biotechnology company, today announced that its board of directors has authorized additional repurchases of up to $5 billion in Amgen common stock. The company currently has $2 billion remaining under its previous stock repurchase program. This new authorization reflects Amgen’s confidence in its long-term prospects.

MORE ON THIS TOPIC